clinical trial · NCT07199309
A Mechanistic Study of MAR001 in Adults With Elevated Triglycerides and Remnant Cholesterol
HypertriglyceridemiaMAR001Placebo
brief summary
The primary objective of the study is to determine the effect of MAR001 as compared to placebo on levels of the triglycerides (TG) in the postprandial state in adults with elevated TG.
started
Sep 26, 2025
primary completion
Jul 1, 2026
completion
Nov 1, 2026
last updated
Nov 6, 2025
official title
Phase 2 Randomized, Double-Blind, Placebo-Controlled Study of MAR001 on Postprandial Lipids in Patients With Elevated Triglycerides and Remnant Cholesterol
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol